Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

MEKK 15 Inhibitors

MEKK 15 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of MEKK 15, a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family. MEKK 15 plays a pivotal role in the MAPK signaling cascade, which is involved in regulating various cellular processes such as growth, differentiation, apoptosis, and stress responses. As a MAPKKK, MEKK 15 acts upstream in the signaling pathway, phosphorylating and activating downstream kinases like MAPKKs (MAP kinase kinases), which in turn activate MAP kinases. This cascade amplifies signals received from cell surface receptors, enabling the cell to respond appropriately to environmental stimuli. Inhibiting MEKK 15 disrupts this signaling pathway, leading to alterations in how cells respond to signals related to survival, proliferation, or stress.

The mechanism of action for MEKK 15 inhibitors generally involves blocking the kinase domain of the protein, preventing it from catalyzing the phosphorylation of downstream kinases. These inhibitors may bind to the ATP-binding site of MEKK 15, which is essential for its kinase activity, or they may interfere with the protein's ability to interact with its substrates or regulatory proteins. Researchers use MEKK 15 inhibitors to study the MAPK signaling pathway and to better understand the role of MEKK 15 in cellular responses to stress, growth signals, and other external factors. By inhibiting MEKK 15, scientists can investigate how the disruption of this signaling cascade affects various biological processes, shedding light on the molecular mechanisms that control cellular decision-making and adaptation. These inhibitors are crucial tools for exploring the broader regulatory networks involved in kinase signaling and the specific contributions of MEKK 15 to maintaining cellular function and homeostasis.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(5Z)-7-Oxozeaenol

253863-19-3sc-202055
sc-202055A
1 mg
5 mg
$154.00
$633.00
13
(1)

This TAK1 inhibitor could directly inhibit MEKK15 by stalling its activation, as structural similarities in their kinase domains suggest susceptibility to this compound.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059 is known to specifically inhibit MEK activation, which could result in the downstream suppression of MEKK15 expression by disrupting the MEK-ERK signaling axis.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As a JNK pathway blocker, SP600125 may halt the signaling cascade required for MEKK15 expression, leading to its decreased transcription.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

By blocking MEK1/2, U0126 could result in decreased transcriptional levels of MEKK15 due to disruptions in the MEK-ERK pathway, which is upstream of MEKK15.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 targets PI3K, potentially leading to reduced MEKK15 expression by cutting off upstream PI3K/Akt signaling that might drive MEKK15 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

As an mTOR inhibitor, Rapamycin could downregulate MEKK15 expression by dismantling the mTOR signaling network, which is integral for kinase expression and activity.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib, as a multi-kinase inhibitor, may lead to the reduced expression of MEKK15 by blocking the RAF/MEK/ERK pathway, which is crucial for its expression.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Imatinib, by inhibiting c-Abl kinase, could lead to a decrease in MEKK15 expression by interrupting the Abl-kinase signaling that can upregulate MEKK15 transcription.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB 203580, by targeting p38 MAP kinase, might reduce MEKK15 expression via the p38 MAPK pathway, which interacts with stress-induced kinase expression pathways.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$112.00
$163.00
$928.00
19
(1)

This MEK inhibitor could decrease MEKK15 expression by blocking the MEK component of the MAPK pathway, which is closely related to MEKK15 activity.